Daclatasvir plus asunaprevir in treatment-naïve patients with hepatitis C virus genotype 1b infection
Sign Up to like & getrecommendations! Published in 2018 at "World Journal of Gastroenterology"
DOI: 10.3748/wjg.v24.i12.1361
Abstract: AIM To assess daclatasvir plus asunaprevir (DUAL) in treatment-naïve patients from mainland China, Russia and South Korea with hepatitis C virus (HCV) genotype 1b infection. METHODS Patients were randomly assigned (3:1) to receive 24 wk… read more here.
Keywords: daclatasvir plus; treatment; infection; treatment patients ... See more keywords